Locations:
Search IconSearch
April 15, 2019/Neurosciences/Research

Is Intraoperative Multimodal Monitoring Indicated for PSOs of the Lumbar Spine?

Retrospective analysis finds no evidence of benefit, but more study needed

19-NEU-272-Spine-Steinmetz-650×450

Intraoperative multimodal (IOM) monitoring, which provides real-time feedback on spinal cord integrity, did not lead to better outcomes in patients undergoing a pedicle subtraction osteotomy (PSO) of the lumbar spine during a decade’s experience involving 101 patients at Cleveland Clinic. So concludes a retrospective study presented at the American Association of Neurological Surgeons (AANS) 2019 annual scientific meeting this week.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Monitoring uses a lot of resources and sometimes leads to false-positive findings, so it’s important to evaluate whether it’s useful,” says senior author Michael Steinmetz, MD, Chair of Neurosurgery at Cleveland Clinic. “Although we didn’t detect benefits from IOM monitoring during PSOs of the lumbar spine, we must still consider whether there’s a very small chance that it prevents a life-changing injury, which would make monitoring worthwhile.”

Picture for lumbar surgery less clear than for thoracic

IOM monitoring — which most commonly uses motor and somatosensory evoked potentials and spontaneous (free-running) electromyography — has largely become standard practice for PSOs of the thoracic spine. It is used in an effort to minimize accidental neurological injury to the spinal cord, nerve roots and associated structures. Iatrogenic injury from surgery to correct a spine deformity can range from minor sensory disturbances to complete paralysis.

But while benefits of IOM monitoring for PSOs on the thoracic spine have been documented in other studies, its usefulness is less certain for PSOs of the lumbar spine, where the spinal cord typically extends only to the level of the first or second lumbar vertebra. Accordingly, guidelines for its use in this setting have not been established. As a result, whether IOM monitoring is used during a PSO of the lumbar spine is largely a matter of surgeon preference.

In a recent narrative literature review (Clin Spine Surg. 2018 Nov 6 [Epub ahead of print]) of IOM monitoring for PSOs of the lumbar spine, a team of Cleveland Clinic authors led by Dr. Steinmetz concluded that more research is needed to establish the risks and benefits and to set guidelines for IOM monitoring in this setting.

Advertisement

Study design and findings

For the study presented at the AANS meeting, a retrospective chart review was conducted of adult patients at Cleveland Clinic who underwent a lumbar PSO from 2007 to 2017. A total of 101 patients were included in the analysis, with the procedures being performed with or without IOM guidance according to surgeon preference.

Patients were evaluated with the self-reported 39-item Parkinson’s Disease Questionnaire (PDQ-39) at baseline and at three months after surgery. Patients who did and did not receive IOM monitoring during their operation were compared in terms of PDQ-39 quality-of-life (QOL) scores and also in terms of the proportions who achieved a minimal clinically important difference (MCID) in PDQ-39 score, defined as an increase of 4.72 points, from baseline to three-month follow-up. Multivariate analysis was used.

No statistically significant differences were found between patients who did and did not receive IOM monitoring in QOL scores (P = 0.230) or in MCID achievement at three months (P = 0.196). Factors that did have a statistically significant impact on rates of achieving MCID were younger age and female sex.

A mandate for more research

Dr. Steinmetz notes that IOM monitoring is progressively becoming the standard of care in surgeries for spinal deformity for good reason: Its utility for preventing nerve and cord injury during thoracic surgery has been established.

He says the jury is still out on whether it is worthwhile for surgeries of the lumbar spine, although this study’s findings could increase the level of confidence for surgeons who choose not to monitor during these types of operations.

Advertisement

Dr. Steinmetz’s research group is currently planning a large, prospective multicenter study to help resolve these unknowns and advance toward establishing practice guidelines.

“While it is possible that IOM monitoring is not needed for PSOs of the lumbar spine, there may be specific circumstances in which it is useful, or certain types of monitoring may be more helpful than others,” he adds. “A large data set can help us determine these nuances and make evidence-based recommendations.”

Advertisement

Related Articles

Illustration of a brain
November 6, 2024/Neurosciences/Research
Genomic Analysis Finds Connections Between Transposable Elements and Alzheimer's Disease

Understanding TE involvement is a key to developing new treatments

Man on an exercise bicycle
October 29, 2024/Neurosciences/Research
New Parkinson’s Trial Focuses on Interplay Between Exercise and Genetics

Study aims to inform an enhanced approach to exercise as medicine

researcher in dark laboratory
September 12, 2024/Neurosciences/Research
Preclinical Imaging Research Aims to Help Refine Deep Brain Stimulation for Stroke Recovery

$3.2 million grant will fund use of calcium-based imaging to record neuronal activity in ischemia model

neurons, axons and synapses in the brain
September 5, 2024/Neurosciences/Research
A Case Study in Neurotherapeutic Clinical Trial Design and Conduct

New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities

Illustration of brain activity
August 28, 2024/Neurosciences/Research
Brain Research Finds Notable Differences in Changes Based on Sex and Race

Chronic stress, asymptomatic disease affect different brains differently

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

22-NEU-2959102-CQD-Hero-650×450
June 15, 2022/Neurosciences/Research
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

22-NEU-2671014-CQD-650×450-Type
March 9, 2022/Neurosciences/Research
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

Ad